# Allogene (ALLO) — Overview

ALLO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/allo

## Price

Last close $1.34 on Oct 15, 2026. 52-week range $1.05 – $3.06.

## Company profile

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $4.6M |
| Revenue (quarter) | $4.6M |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | −$165.5M |
| Net income (quarter) | −$42.7M |
| Net income growth (year over year) | 16.23% |
| Net margin | -3566.68% |
| Return on equity | -42.39% |
| EPS (trailing twelve months) | −$0.66 |
| Book value per share | $1.26 |
| P/E (trailing twelve months) | — |
| Price to book | 1.1 |
| Debt to assets | 20.71% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Allogene (ALLO) profitable?

No. Allogene reported a net loss of $165.5M over the trailing twelve months.

### How much revenue does Allogene (ALLO) make?

Allogene generated $4.6M in revenue over the trailing twelve months.

### How do I buy stock in Allogene (ALLO)?

ALLO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).